MarketBeat
07 Nov 2026, 16:16 UTC · 1h ago
McKesson Q2 Earnings Call Highlights
Impact · against what's priced in
McKesson's raised FY2027 guidance and strong GLP-1 growth provide a positive catalyst by exceeding previous market assumptions for earnings growth. CVS receives minor positive confirmation regarding operational stability via its extended distribution agreement, though this does little to resolve the margin concerns currently depressing its price.
- MCK+0.50
Challenges what's priced in
- The price assumes
The raised fiscal 2027 adjusted EPS guidance of $44.20 to $45.00
The market had already priced in EPS guidance up to $45.00; the new floor of $45.60 and ceiling of $46.40 represent a material upward revision that exceeds previous assumptions.
What MCK's price assumes · Sep 1
